SHANGHAI – A Chinese vaccine joint venture (JV), Bravovax Co. Ltd., of Wuhan, has taken on the global rights for a rotavirus vaccine to be administered to newborn infants – the first of its kind to protect infants at birth from potentially life threatening diarrhea leading to severe dehydration.